skip to main content

CORPORATE PRESENTATION

We invite you to download our corporate presentation to help understand our unique purpose, our current commercial footprint, and our innovative pipeline.

Quarterly Results

2025

Type Title Interactions
Webcast United Therapeutics Second Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Second Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics Second Quarter 2025 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics First Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics First Quarter 2025 Factsheet PDF

2024

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2024 Financial Results Presentation PDF
Factsheet United Therapeutics Fourth Quarter 2024 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2024 Financial Results Presentation PDF
Factsheet United Therapeutics Third Quarter 2024 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Second Quarter 2024 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics First Quarter 2024 Financial Results Presentation PDF

2023

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2023 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2023 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2022

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2021

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2020

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results Link PDF
SEC Filing
Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF

2019

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF

2018

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2018 Financial Results Link
Press Release United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2018 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF

2017

Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF

2016

Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2016 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF

2015

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF

2014

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF

2013

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF

2012

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF

2011

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF

2010

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF

2009

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF

2008

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF

2007

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF

2006

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF

2005

Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF

2004

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF

Press Releases

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will host a webcast to review data from the successful TETON-2 pivotal study...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that Martine Rothblatt, Ph.D., Chairperson and Chief...
Results of the successful phase 3 TETON-2 study of inhaled treprostinil in idiopathic pulmonary fibrosis will be presented in an oral presentationSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS...
Positive results were observed across all subgroupsStudy meets several key secondary endpoints with statistical significanceSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James Edgemond, Chief Financial Officer and...
Repurchase reflects the strength of United Therapeutics’ balance sheet and confidence in its near-term prospectsSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation...

Events and presentations

28 Sep 2025

Phase 3 TETON-2 Results Conference Call

12:30 PM ET

23 Sep 2025

Bernstein 2nd Annual Healthcare Forum

01:10 PM ET

08 Sep 2025

Morgan Stanley 23rd Annual Global Healthcare Conference

03:20 PM ET

30 Jul 2025

United Therapeutics Second Quarter 2025 Financial Results

09:00 AM ET

30 Apr 2025

United Therapeutics First Quarter 2025 Financial Results

09:00 AM ET

11 Mar 2025

Leerink Partners Global Healthcare Conference

10:00 AM ET

SEC Filings

Corporate Annual Reports

PROXY STATEMENTS